Jeff Geschwind, MD is a key medical advisor for HistoSonics, innovating non-invasive liver cancer therapy. His guidance is crucial in developing technology that destroys tumors without a single incision, offering new hope to patients through groundbreaking soundwave-based treatment. https://issuu.com/jeffgeschwind/docs/targeting_tumor_glycolysis_a_promising_frontier_in